This activity is expired and is no longer available for CME credit.


Use of High-efficacy Agents in the Treatment of Relapsing-Remitting MS

Author(s)/Faculty: Guy J. Buckle, MD, MPH
Release Date: 12/16/2016Expiration Date: 12/15/2017
Credit Type: CME / CNENumber of Credits: 0
Content Type: ArticleProvider:
Multiple sclerosis (MS) is a chronic, immune-mediated inflammatory disease of the central nervous system that affects more than 2.3 million people worldwide. First-line treatments often fail to adequately control disease activity in patients with MS. This case-based activity is designed to help clinicians with the process of treatment optimization in patients with MS and with early switching to high-efficacy therapy with breakthrough disease activity.